Eisen, T
Loembé, A-B
Shparyk, Y
MacLeod, N
Jones, R J
Mazurkiewicz, M
Temple, G
Dressler, H
Bondarenko, I
Article History
Received: 27 February 2015
Revised: 29 July 2015
Accepted: 31 July 2015
First Online: 8 October 2015
Competing interests
: TE is a part-time employee (from 1 September 2014) of AstraZeneca and owns stock or other ownership interest in the company, and has had a consulting or advisory role and received honoraria from Bayer, Pfizer, AVEO Oncology and GlaxoSmithKline. RJJ has received honoraria from Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer and Roche. A-BL, GT and HD are all employees of Boehringer Ingelheim. IB and NM report no conflicts of interest.